Overview
Background
A/Prof Mark D. Chatfield is a highly experienced statistician in the UQ Clinical Trials Centre and collaborates with researchers across the Faculty of Health, Medicine and Behavioural Sciences.
In collaboration with health and medical researchers, he has published >200 times in academic journals. He has been an investigator on 30 NHMRC/MRFF funded (>$57M) studies (mostly clinical trials). He has >20 years of experience as a biostatistician in Australia (Brisbane, Darwin, Sydney) and the UK (Cambridge, 2002-2009). He has co-supervised 7 PhD students to completion, and is currently an advisor to 2 PhD students.
He plays an active role in the Australian Clinical Trials Alliance Statistics in Trials Interest Group.
Stata users around the world enjoy using his table1_mc command.
He is an Honorary Fellow (Associate Professor) with Menzies School of Health Research.
Availability
- Mr Mark Chatfield is:
- Not available for supervision
Fields of research
Qualifications
- Bachelor of Arts, University of Oxford
- Masters (Coursework), University of Southampton
- Masters (Coursework), University of Oxford
Research interests
-
Clinical trials
Mark has been involved with a plethora of trials of various designs in a broad range of fields. He makes significant contributions to funding applications, trial design, analysis, presentation and interpretation. To date, he has published on 39 randomised trials (protocol and/or results paper). He is involved with methodological research into cluster randomised trials as well as sample size calculations.
-
Meta-analysis
Mark has been involved with a variety of meta-analyses. He has found a novel way to interpret the heterogeneity parameter, tau, in random-effects meta-analysis of ratios. That said, he advocates for the reporting of tau, or exp(tau) for ratios, rather than tau^2 as it is most easily understood.
Works
Search Professor Mark Chatfield’s works on UQ eSpace
2011
Journal Article
Low Calretinin Expression and High Neutrophil-To-Lymphocyte Ratio Are Poor Prognostic Factors in Patients with Malignant Mesothelioma Undergoing Extrapleural Pneumonectomy
Kao, Steven Chuan-Hao, Klebe, Sonja, Henderson, Douglas W., Reid, Glen, Chatfield, Mark, Armstrong, Nicola J., Yan, Tristan D., Vardy, Janette, Clarke, Stephen, van Zandwijk, Nico and McCaughan, Brian (2011). Low Calretinin Expression and High Neutrophil-To-Lymphocyte Ratio Are Poor Prognostic Factors in Patients with Malignant Mesothelioma Undergoing Extrapleural Pneumonectomy. Journal of Thoracic Oncology, 6 (11), 1923-1929. doi: 10.1097/JTO.0b013e31822a3740
2011
Conference Publication
Factors Affecting Time From Surgery to Adjuvant Chemotherapy for Early Breast Cancer in a Rural and Urban Medical Oncology Unit - a Retrospective Cohort Study
Fox, P. N., Chatfield, M. D., Beith, J., Turley, K. and Grimison, P. S. (2011). Factors Affecting Time From Surgery to Adjuvant Chemotherapy for Early Breast Cancer in a Rural and Urban Medical Oncology Unit - a Retrospective Cohort Study. European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm Sweden, Sep 23-27, 2011. OXFORD: ELSEVIER SCI LTD. doi: 10.1016/S0959-8049(11)71216-3
2011
Conference Publication
Patterns of Care for Stage 1 Testicular Cancer in Australia in 2010
Houghton, B., Stockler, M., Chatfield, M. D., Toner, G., Davis, I. D. and Grimison, P. S. (2011). Patterns of Care for Stage 1 Testicular Cancer in Australia in 2010. European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm Sweden, Sep 23-27, 2011. OXFORD: ELSEVIER SCI LTD.
2011
Conference Publication
MARKERS OF PROGNOSIS IN RESECTED STAGE IB NON-SMALL CELL LUNG CANCER (NSCLC)
Yip, Po Yee, Cooper, Wendy, Mahar, Annabelle, Kench, James, Kohonen-Corish, Maija R. J., Chatfield, Mark, Boulghourjian, Alice, Kennedy, Catherine W., Mccaughan, Brian, Boyer, Michael and Horvath, Lisa (2011). MARKERS OF PROGNOSIS IN RESECTED STAGE IB NON-SMALL CELL LUNG CANCER (NSCLC). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.
2011
Conference Publication
PROGNOSTIC FACTORS IN MALIGNANT PLEURAL MESOTHELIOMA (MPM) IN A COHORT OF PATIENTS COMPENSATED BY THE DUST DISEASES BOARD
Kao, Steven C., Clarke, Stephen, Chatfield, Mark, Corte, Peter, Clarke, Christopher, Vardy, Janette and Van Zandwijk, Nico (2011). PROGNOSTIC FACTORS IN MALIGNANT PLEURAL MESOTHELIOMA (MPM) IN A COHORT OF PATIENTS COMPENSATED BY THE DUST DISEASES BOARD. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.
2011
Conference Publication
CALRETININ EXPRESSION IMPROVES THE PREDICTIVE ACCURACY IN SURVIVAL IN PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA (MPM) UNDERGOING EXTRAPLEURAL PNEUMONECTOMY (EPP)
Kao, Steven C., Klebe, Sonja, Henderson, Douglas W., Reid, Glen, Chatfield, Mark, Armstrong, Nicola, Yan, Tristan, Vardy, Janette, Clarke, Stephen, Van Zandwijk, Nico and Mccaughan, Brian (2011). CALRETININ EXPRESSION IMPROVES THE PREDICTIVE ACCURACY IN SURVIVAL IN PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA (MPM) UNDERGOING EXTRAPLEURAL PNEUMONECTOMY (EPP). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.
2011
Conference Publication
A study of <i>methylated glutathione s-transferase 1 (mGSTP1)</i> as a potential plasma epigenetic marker of response to chemotherapy and prognosis in men with castration-resistant prostate cancer (CRPC)
Horvath, L., Mahon, K. L., Qu, W., Devaney, J., Chatfield, M. D., Paul, C., Wykes, R., Boyer, M. J., Stockler, M. R., Marx, G. M., Sutherland, R. L. and Clark, S. J. (2011). A study of methylated glutathione s-transferase 1 (mGSTP1) as a potential plasma epigenetic marker of response to chemotherapy and prognosis in men with castration-resistant prostate cancer (CRPC). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/jco.2011.29.15_suppl.4603
2011
Conference Publication
Accelerated BEP for advanced germ cell tumors: An Australian multicenter phase I/II trial
Grimison, P. S., Thomson, D. B., Stockler, M. R., Chatfield, M. D., Friedlander, M., Gebski, V., Boland, A. L., Houghton, B. B., Gurney, H., Rosenthal, M., Singhal, N., Kichenadasse, G., Wong, S. S., Lewis, C. R., Vasey, P. A. and Toner, G. C. (2011). Accelerated BEP for advanced germ cell tumors: An Australian multicenter phase I/II trial. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/jco.2011.29.15_suppl.4561
2011
Conference Publication
Morphologic and immunohistochemical (IHC) changes in metastatic melanoma (MM) tissue and associations with clinical outcome in patients (pts) on BRAF inhibitors (BRAFi)
Long, G. V., Wilmott, J. S., Howle, J. R., Chatfield, M. D., Tembe, V., Thompson, J. F., Hersey, P., Mann, G. J., McArthur, G. A., Rizos, H., Young, R. J., Scurr, L. L., Sharma, R. N., Kefford, R. F. and Scolyer, R. A. (2011). Morphologic and immunohistochemical (IHC) changes in metastatic melanoma (MM) tissue and associations with clinical outcome in patients (pts) on BRAF inhibitors (BRAFi). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/jco.2011.29.15_suppl.8542
2011
Conference Publication
BRAF mutation by age-decade and body mass index in metastatic melanoma
Menzies, A. M., Visintin, L., Chatfield, M. D., Carlino, M. S., Howle, J. R., Scolyer, R. A., Thompson, J. F., Kefford, R. F. and Long, G. V. (2011). BRAF mutation by age-decade and body mass index in metastatic melanoma. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY.
2011
Conference Publication
Cytokines' profiles to predict chemotherapy outcome in castration-resistant prostate cancer (CRPC)
Mahon, K. L., Chatfield, M. D., Lee-Ng, M., Breit, S. N., Brown, D. A., Molloy, M. P., Marx, G. M., Pavlakis, N., Boyer, M. J., Stockler, M. R., Wykes, R., Henshall, S. M., Sutherland, R. L. and Horvath, L. (2011). Cytokines' profiles to predict chemotherapy outcome in castration-resistant prostate cancer (CRPC). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/jco.2011.29.15_suppl.4598
2011
Journal Article
Clinical validation study to measure the performance of the nerve root sedimentation sign for the diagnosis of lumbar spinal stenosis
Staub, Lukas P., Barz, Thomas, Melloh, Markus, Lord, Sarah J., Chatfield, Mark and Bossuyt, Patrick M. (2011). Clinical validation study to measure the performance of the nerve root sedimentation sign for the diagnosis of lumbar spinal stenosis. Contemporary Clinical Trials, 32 (3), 470-474. doi: 10.1016/j.cct.2011.01.015
2011
Conference Publication
The effect of pulmonary function testing on bleomycin dosing in germ cell tumors
Houghton, B. B., Grimison, P. S., Toner, G. C., Chatfield, M., Thomson, D. B., Friedlander, M., Gebski, V., Rosenthal, M., Gurney, H. and Stockler, M. (2011). The effect of pulmonary function testing on bleomycin dosing in germ cell tumors. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/jco.2011.29.7_suppl.227
2011
Journal Article
The reliability of assigning individuals to cognitive states using the Mini Mental-State Examination: a population-based prospective cohort study
Marioni, Riccardo E., Chatfield, Mark, Brayne, Carol, Matthews, Fiona E. and Medical Research Council Cognitive Function and Ageing Study Group (2011). The reliability of assigning individuals to cognitive states using the Mini Mental-State Examination: a population-based prospective cohort study. BMC Medical Research Methodology, 11 (1) 127, 127.1-127.6. doi: 10.1186/1471-2288-11-127
2010
Journal Article
Validity of a New Abdominal Bioelectrical Impedance Device to Measure Abdominal and Visceral Fat: Comparison With MRI
Browning, Lucy M., Mugridge, Owen, Chatfield, Mark D., Dixon, Adrian K., Aitken, Sri W., Joubert, Ilse, Prentice, Andrew M. and Jebb, Susan A. (2010). Validity of a New Abdominal Bioelectrical Impedance Device to Measure Abdominal and Visceral Fat: Comparison With MRI. Obesity, 18 (12), 2385-2391. doi: 10.1038/oby.2010.71
2010
Journal Article
Effect of changing the amount and type of fat and carbohydrate on insulin sensitivity and cardiovascular risk: the RISCK (Reading, Imperial, Surrey, Cambridge, and Kings) trial
Jebb, Susan A., Lovegrove, Julie A., Griffin, Bruce A., Frost, Gary S., Moore, Carmel S., Chatfield, Mark D., Bluck, Les J., Williams, Christine M. and Sanders, Thomas A. B. (2010). Effect of changing the amount and type of fat and carbohydrate on insulin sensitivity and cardiovascular risk: the RISCK (Reading, Imperial, Surrey, Cambridge, and Kings) trial. American Journal of Clinical Nutrition, 92 (4), 748-758. doi: 10.3945/ajcn.2009.29096
2010
Journal Article
Markers of cardiovascular risk are not changed by increased whole-grain intake: the WHOLEheart study, a randomised, controlled dietary intervention
Brownlee, Iain A., Moore, Carmel, Chatfield, Mark, Richardson, David P., Ashby, Peter, Kuznesof, Sharron A., Jebb, Susan A. and Seal, Chris J. (2010). Markers of cardiovascular risk are not changed by increased whole-grain intake: the WHOLEheart study, a randomised, controlled dietary intervention. British Journal of Nutrition, 104 (1), 125-134. doi: 10.1017/S0007114510000644
2010
Conference Publication
Randomized, controlled pilot trial of electro-acupuncture for nausea, vomiting, and myelosuppression in women receiving adjuvant chemotherapy for early breast cancer
Beith, J. M., Oh, B., Orme, K., McLean, A., Chatfield, M. and Venkateswaran, R. (2010). Randomized, controlled pilot trial of electro-acupuncture for nausea, vomiting, and myelosuppression in women receiving adjuvant chemotherapy for early breast cancer. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/jco.2010.28.15_suppl.e19630
2010
Conference Publication
Measuring abdominal and visceral adipose tissue: comparison of data from simpler techniques with MRI
Mugridge, O., Browning, L. M., Chatfield, M., Dixon, A. K., Prentice, A. M. and Jebb, S. A. (2010). Measuring abdominal and visceral adipose tissue: comparison of data from simpler techniques with MRI. CAMBRIDGE: CAMBRIDGE UNIV PRESS. doi: 10.1017/S0029665110001461
2009
Journal Article
An algorithm to assess intestinal iron availability for use in dietary surveys
Rickard, Anna P., Chatfield, Mark D., Conway, Rana E., Stephen, Alison M. and Powell, Jonathan J. (2009). An algorithm to assess intestinal iron availability for use in dietary surveys. British Journal of Nutrition, 102 (11), 1678-1685. doi: 10.1017/S0007114509990894
Funding
Current funding
Past funding
Supervision
Availability
- Mr Mark Chatfield is:
- Not available for supervision
Supervision history
Current supervision
-
Doctor Philosophy
Epidemiology and clinical outcomes of gram-negative bloodstream infections in children
Associate Advisor
Other advisors: Dr Geoff Spurling, Professor Colleen Lau, Associate Professor Adam Irwin
-
Doctor Philosophy
Novel trial design in evaluation of antibiotics.
Associate Advisor
Other advisors: Dr Patrick Harris
Completed supervision
-
2025
Doctor Philosophy
Treatment Strategies for Extended-Spectrum Beta-Lactamase (ESBL) and AmpC-producing Enterobacterales
Associate Advisor
Other advisors: Dr Patrick Harris, Dr Brian Forde
-
2025
Doctor Philosophy
Exploring the use of causal inference in infectious disease epidemiology
Associate Advisor
Other advisors: Professor Tracy Comans, Professor Lisa Hall
-
2024
Doctor Philosophy
Burkholderia pseudomallei: towards rapid diagnosis and management
Associate Advisor
Other advisors: Dr Patrick Harris
-
Media
Enquiries
For media enquiries about Mr Mark Chatfield's areas of expertise, story ideas and help finding experts, contact our Media team: